Suppr超能文献

通过 CO2 饱和乳液的沉淀法制备用于药物传递的多核杂化颗粒。

Development of multicore hybrid particles for drug delivery through the precipitation of CO2 saturated emulsions.

机构信息

Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Avenida da Republica, 2780-157 Oeiras, Portugal; Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2781-901 Oeiras, Portugal.

High Pressure Processes Group, Department of Chemical Engineering and Environmental Technology, University of Valladolid, Doctor Mergelina, 47011 Valladolid, Spain.

出版信息

Int J Pharm. 2015 Jan 15;478(1):9-18. doi: 10.1016/j.ijpharm.2014.11.003. Epub 2014 Nov 6.

Abstract

Hybrid lipid-polymer particles are gaining increasing interest to be applied as drug delivery systems due to their greater stability in biological fluids and enhanced cellular uptake of drugs. However, a major drawback is the fact that these particles are usually produced through techniques that use organic solvents. This work studies the possibility of producing for the first time hybrid particles composed by lipid multicores enveloped in a polymeric layer through Particles from Gas Saturated Solutions (PGSS(®)), without using organic solvents. An oil-in-water emulsion, composed by Gelucire 43/01™ (GEL) as the discontinuous phase and by an aqueous polyethylene glycol 4000 (PEG) solution as the continuous phase, was successfully precipitated by PGSS(®). Operating conditions that ensured the stability of the CO2 saturated emulsion were previously evaluated. The resulting PEG-GEL particles present a spherical-like morphology constituted by several lipid cores encapsulated into a polymeric shell. The applicability of these structured particles to be used as drug delivery system (DDS) was studied by using ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID), as model drug. The particles provided an initial burst release of the drug due to the progressive dissolution of the external layer of PEG, followed by a controlled release of the NSAID from the GEL cores.

摘要

混合脂质-聚合物颗粒由于其在生物流体中的更高稳定性和增强的药物细胞摄取而越来越受到关注,可作为药物传递系统。然而,一个主要的缺点是这些颗粒通常是通过使用有机溶剂的技术生产的。本工作首次研究了通过气体饱和颗粒溶液(PGSS(®))生产由脂质多芯包封在聚合物层中的混合颗粒的可能性,而不使用有机溶剂。由 Gelucire 43/01™(GEL)作为不连续相和由聚乙二醇 4000(PEG)水溶液作为连续相组成的油包水乳液通过 PGSS(®)成功沉淀。先前已经评估了确保 CO2 饱和乳液稳定性的操作条件。所得的 PEG-GEL 颗粒具有球形形态,由几个脂质核封装在聚合物壳中。通过使用酮洛芬作为模型药物研究了这些结构化颗粒作为药物传递系统(DDS)的适用性。由于外部 PEG 层的逐渐溶解,颗粒提供了药物的初始突释,随后从 GEL 核中控制释放 NSAID。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验